Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose



Status:Recruiting
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 40
Updated:2/27/2019
Start Date:February 28, 2019
End Date:January 31, 2020
Contact:Stephen McNulty, DO
Email:Stephen.McNulty@Jefferson.edu
Phone:215-955-6161

Use our guide to learn which trials are right for you!

RTM Vital Signs, LLC is developing a miniature wearable tracheal sound sensor that
communicates with a cell phone containing a machine-learning diagnostic algorithm designed to
detect and predict the onset of mild, moderate, and severe hypoventilation (respiratory
depression) due to an opioid overdose. The purpose of this clinical trial is to
develop/validate diagnostic algorithms capable of detecting/predicting the onset of
hypoventilation induced by a controlled intravenous infusion of fentanyl. The wearable sensor
and algorithms will provide a series of alerts and alarms to the person, caregiver, and/or
emergency personnel.

More than 64,000 Americans died from a drug overdose in 2016 and drug overdose is now the
most common cause of death for people under 50 years old in the United States. The purpose of
this study is to design a wearable tracheal sound sensor and develop an experimental computer
program (diagnostic algorithm) that can accurately detect and predict the onset of mild,
moderate, and severe hypoventilation (slow and shallow breathing) due to an opioid (fentanyl)
overdose

Opioid pain medications routinely cause a person's breathing to become slower and shallower,
leading to an increased amount of carbon dioxide and decreased amount of oxygen in the
bloodstream. Microphone trachea sound sensors will be used to measure and record sounds
produced by air movement in and out of a person's trachea (windpipe) during inhalation and
exhalation. Blood will be frequently sampled from a catheter placed within a wrist artery to
measure the concentration of carbon dioxide and oxygen. An intravenous infusion of fentanyl
will be used to decrease the person's respiratory rate and depth of breathing over a 1 to 3
hour period. Other sensors will be used to accurately measure and record the person's
respiratory rate, tidal volume, hemoglobin oxygen saturation, electrocardiogram, blood
pressure, temperature, body activity level, and body position. Each sensor's output signal
will be processed and filtered to enhance the signal-to-noise ratio. The Trachea Sound Sensor
and reference respiratory sensor information will be used to develop/validate risk-index
algorithms that can recognize a significant change in an individual's "normal or baseline"
pattern of respiratory rate, tidal volume, body activity, and body position. The
hypoventilation monitoring system will not require previous knowledge of an individual's age,
height, weight, model of the respiratory tract, or external calibration.

Inclusion Criteria:

1. Healthy women/men between 18 and 40 years of age.

2. Negative history of drug or alcohol abuse.

3. Negative history of cigarette smoking in previous 6 months.

4. Negative history of active cardiac, vascular, pulmonary, renal, hepatic, nervous,
metabolic or immune disease.

5. BMI < 30

Exclusion Criteria:

1. Age < 18 years and > 40 years.

2. Pregnant or planning to become pregnant.

3. Positive history drug or alcohol abuse.

4. Positive drug screen for opioids, benzodiazepines, hypnotics.

5. Positive Drug Abuse Screening Test result (score of 6 or greater).

6. BMI > 30

7. History of sleep apnea.

8. History of cigarette smoking in previous 6 months.

9. History of difficult airway during anesthesia management.

10. History of allergy or skin sensitivity to tape, silicone, fentanyl, chlorhexidine.
We found this trial at
1
site
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Phone: 215-955-6161
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials